Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ, Hamulyák K.
Semin Thromb Hemost. 1998;24(4):309-20. doi: 10.1055/s-2007-996019.
Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
Nadar SK, Al Yemeni E, Blann AD, Lip GY.
Thromb Res. 2004;113(2):123-8. doi: 10.1016/j.thromres.2004.02.010.
Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
Dusse LM, Cooper AJ, Lwaleed BA.
Clin Chim Acta. 2007 Mar;378(1-2):1-6. doi: 10.1016/j.cca.2006.10.014. Epub 2006 Oct 26.
Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia.
Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K.
Crit Care Med. 2009 Jul;37(7):2181-6. doi: 10.1097/CCM.0b013e3181a55184.
Dyslipidemias and fibrinolysis.
Puccetti L, Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Auteri A.
Ital Heart J. 2002 Oct;3(10):579-86.
Carboxypeptidase R is an inactivator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis.
Campbell W, Okada N, Okada H.
Immunol Rev. 2001 Apr;180:162-7. doi: 10.1034/j.1600-065x.2001.1800114.x.
Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.
Wan J, Vadaq N, Konings J, Jaeger M, Kumar V, de Laat B, Joosten L, Netea MG, van der Ven AJ, de Groot PG, de Mast Q, Roest M.
J Thromb Haemost. 2022 Jan;20(1):48-57. doi: 10.1111/jth.15530. Epub 2021 Sep 28.
Plasma thrombomodulin concentrations in relation to cardiovascular risk factors in a population sample.
Nilsson TK, Hellsten G, Amiral J.
Blood Coagul Fibrinolysis. 1993 Jun;4(3):455-8. doi: 10.1097/00001721-199306000-00010.
Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor.
Kottke-Marchant K, Comp P.
Arch Pathol Lab Med. 2002 Nov;126(11):1337-48. doi: 10.5858/2002-126-1337-LIIDAO.
Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
Ruszkowska B, Sokup A, Kulwas A, Kwapisz J, Góralczyk K, Socha MW, Rhone P, Rość D.
Acta Obstet Gynecol Scand. 2013 Jul;92(7):841-6. doi: 10.1111/aogs.12136. Epub 2013 Apr 18.
